In vitro evaluation of cefepime and other broad-spectrum β-lactams in Taiwan medical centers
- 1 December 1999
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 35 (4) , 299-305
- https://doi.org/10.1016/s0732-8893(99)00106-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in JapanDiagnostic Microbiology and Infectious Disease, 1999
- Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatmentInternational Journal of Antimicrobial Agents, 1998
- Multicenter evaluation of antimicrobial resistance to six broad-spectrum β-lactams in Colombia using the etest methodDiagnostic Microbiology and Infectious Disease, 1997
- Cefepime/Amikacin Versus Ceftazidime/Amikacin as Empirical Therapy for Febrile Episodes in Neutropenic Patients: A Comparative StudyClinical Infectious Diseases, 1997
- Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in TaiwanDiagnostic Microbiology and Infectious Disease, 1994
- CefepimeDrugs, 1994
- A non-comparative study of the efficacy and tolerance of cefepime in combination with amikacin in the treatment of severe infections in patients in intensive careJournal of Antimicrobial Chemotherapy, 1993
- Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patientsJournal of Antimicrobial Chemotherapy, 1993
- Factors involved in the enhanced efficacy against Gram-negative bacteria of fourth generation cephalosporinsJournal of Antimicrobial Chemotherapy, 1992
- Evaluation of the E test, a novel method of quantifying antimicrobial activityJournal of Antimicrobial Chemotherapy, 1991